weekly_bull3

The Week in Review: September 15, 2017 – September 22, 2017

Friday, September-22-17

News Recap

Epclusa approved for HIV-HCV coinfection in Canada, generic sofosbuvir approved in Malaysia, unrestricted access to Epclusa and Harvoni in Switzerland, new study on financial burden of liver disease, predictors of fibrosis progression in HBV……..

Read more…http://hepcbc.ca/2017/09/22/week-review-september-15-september-22-2017/

red line

The Week in Review: September 8, 2017 – September 15, 2017

Friday, September-15-17

News Recap

Rosemary Plummer steps down as President of HepCBC; rest of the Board re-elected at AGM; Women and HCV; How Liver Cancer Develops; Global Burden of Disease, Johnson & Johnson pulls plug on Medivir-Achillion hep C cocktail to focus on hep B……..

Read more…http://hepcbc.ca/2017/09/15/week-review-september-8-september-15-2017/

red line

The Week in Review: September 1, 2017 – September 8, 2017

Friday, September-8-17

News Recap

Mystery illness solved, DAAs and kidney disease, drug paraphernalia and transmission, fibrosis progression in men and the last word on DAAs and HCC?

Read more…http://hepcbc.ca/2017/09/08/week-review-september-1-september-8-2017/

red line

2017

August Archive:

July Archive:

June Archive:

May Archive:

April Archive:

March Archive:

February Archive:

January Archive:

 

2016

December Archive:

November Archive:

October Archive:

September Archive: